Alytix
PrivateLast Round
Series A
Jun 1, 2021
Total Funding Raised
$8.05M
Company Overview
Alytix operates in Healthcare & Life Sciences and is based in Santa Fe, Santa Fe. Its latest recorded funding round was a Series A round in June 2021.
Alytix is a biotechnology company that develops bacteriophage-based antibiotic alternatives to treat bacterial infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alytix Comparables
Compare Alytix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PhageLab | 87% | |
| Phagos | 87% | |
| Proteon Pharmaceuticals | 78% |
For institutional investors. Book with your work email.
Alytix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 1, 2021 | ||||
| Seed | May 1, 2020 | ||||
| Pre Seed | Apr 3, 2019 | ||||
| Accelerator | Sep 24, 2018 |
For institutional investors. Book with your work email.
Alytix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Series A, Pre Seed, Seed |
| GRIDX | Accelerator |
| Elm Street Ventures | Series A |
| Life Science Angels | Series A |
| Harrington Discovery Institute | Series A |
| Spring Mountain Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 24, 2018
$200K round led by GRIDX
For institutional investors. Book with your work email.
Alytix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Alytix's valuation, stock price, and market status.
Is Alytix a public or private company?
Alytix is a private company.
What is the current stock price of Alytix?
Alytix is a private company, so its shares have no public market price. Caplight tracks Alytix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Alytix worth (valuation)?
Valuation information for Alytix is not publicly available.
Can I buy Alytix stock?
Alytix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Alytix's last funding round?
Alytix's most recent funding round was Series A on June 1, 2021.
Who are the main investors in Alytix?
Key investors in Alytix include GRIDX, Elm Street Ventures, Spring Mountain Capital.
Will Alytix IPO soon?
No public IPO plans have been announced for Alytix.
How can I track Alytix secondary market activity?
Caplight tracks bids, offers, and trades in Alytix's shares on secondary markets.